Clinical Trial Update: Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating sitagliptin's effects on intestinal and hepatic lipoprotein particles and hepatic glucose production in humans with hyperlipidemia; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hyperlipidemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-05-05